| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/05/2010 | US7642362 Compounds as semaphorin inhibitors |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2424512C Delivery system and method of treating or preventing otitis media |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2287780C Use of nerve growth factor for the storage, culture or treatment of cornea |
| 12/31/2009 | US20090326074 Alkoxy compounds for disease treatment |
| 12/31/2009 | US20090326050 Di(uridine 5'-)tetraphosphate and salts thereof |
| 12/31/2009 | US20090326034 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325970 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 12/31/2009 | US20090325959 Method for treating ophthalmic diseases using rho kinase inhibitor compounds |
| 12/31/2009 | US20090324691 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 12/31/2009 | US20090324690 Transscleral delivery |
| 12/31/2009 | US20090324689 inhibiting the transition from the dry form of age-related macular degeneration to the wet form with rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; implants |
| 12/31/2009 | US20090324688 Transscleral delivery |
| 12/31/2009 | US20090324687 Transscleral delivery |
| 12/31/2009 | US20090324686 mTOR inhibitor effective to treat macular edema; rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; treatment of wet age related macular degeneration |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/30/2009 | WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 12/30/2009 | WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/30/2009 | WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 12/30/2009 | WO2009129187A3 Combination therapy for glaucoma |
| 12/30/2009 | WO2009077736A3 A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist |
| 12/30/2009 | EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria |
| 12/30/2009 | EP2138170A2 Prevention and Treatment of Oxidative Stress Disorders by compounds which elevate intracellular levels of glutathione or Phase II Detoxification Enzymes |
| 12/30/2009 | EP2136816A2 Oleyl phosphocholine |
| 12/30/2009 | EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CN100574787C Chinese medicine composition orally taken for curing glaucoma |
| 12/30/2009 | CN100574772C Soft capsule containing lutein and its preparation method |
| 12/30/2009 | CA2728137A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 12/30/2009 | CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/30/2009 | CA2728112A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
| 12/29/2009 | US7638518 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 12/29/2009 | US7638516 Agent for therapeutic treatment of optic nerve diseases and the like |
| 12/29/2009 | US7638511 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 12/24/2009 | US20090318549 Combination treatment of glaucoma |
| 12/24/2009 | US20090318545 Mast cell inhibition in diseases of the retina and vitreous |
| 12/24/2009 | US20090318515 Succinimide derivatives as ocular hypotensive agents |
| 12/24/2009 | US20090318485 Novel inhibitors of rho kinase |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318424 Novel compounds |
| 12/24/2009 | US20090318397 Combination of Azelastine and Steroids |
| 12/24/2009 | US20090318342 Compounds |
| 12/24/2009 | US20090317503 Eyelid Preparation and Method of Use |
| 12/24/2009 | US20090317448 Tympanic membrane patch |
| 12/24/2009 | US20090317405 Antibody and uses thereof |
| 12/24/2009 | DE102008027868A1 Substance, useful to produce composition or medicament to treat otological disorders, preferably tinnitus and hearing disorders, comprises mixture of Chenopodium, quinine, acetylsalicylic acid and Conium maculatum in homeopathic dilution |
| 12/23/2009 | WO2009154873A2 Use of novel lipid mediators to inhibit angiogenesis |
| 12/23/2009 | WO2009154766A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 12/23/2009 | WO2009152584A1 Synthesis of ageladine a and analogs thereof |
| 12/23/2009 | WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/23/2009 | WO2009117365A3 Vaccine compositions for inducing immune responses against components of drusen |
| 12/23/2009 | EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1420787B1 Ophthalmic composition comprising an ascomycin |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 12/23/2009 | CN101607077A Traditional Chinese medicine composition for treating vertigo and preparation method thereof |
| 12/23/2009 | CN101607005A Application of Chinese medicinal composition in preparing medicament for treating conjunctivitis |
| 12/23/2009 | CN101606989A Novel preparation method of trollius chinensis granular preparation |
| 12/23/2009 | CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 12/23/2009 | CN101606932A Application of 17-AAG for preparing eye RPE cell VEGF inhibiting agent |
| 12/23/2009 | CN100571772C Use of integrin receptor alpha v beta 3 and /or alpha v beta 5 antagonist in preparing medicine for treating eye disease |
| 12/23/2009 | CA2727987A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same |
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635469 Micronutrient formulations for hearing health |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | CA2418059C Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 12/22/2009 | CA2417282C Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 12/22/2009 | CA2415214C Phosphotetrahydropyran compounds |
| 12/22/2009 | CA2414514C Carbamates derived from arylalkylamines |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |